Literature DB >> 11488992

Effects of hyaluronan on the invasive properties of human breast cancer cells in vitro.

A Herrera-Gayol1, S Jothy.   

Abstract

Hyaluronan (HA) is a high molecular weight glycosaminoglycan present mostly in the extracellular matrix (ECM). HA binds to specific receptors such as CD44. Its production is increased at the tumour-stroma interface, including those in breast cancer tumours. It has been suggested that it facilitates invasion of tumour cells into the ECM by a hydrodynamic effect, or by altering tumour cell behaviour. Using in vitro tests we studied the effect of immobilized (iHA) and soluble (sHA) HA on the invasive properties of four human breast cancer cell lines with different levels of CD44 expression. Our results show that iHA acts as an adhesive, haptotactic, and motility stimulating factor for the CD44 positive Hs578T cells and induces the expression of membrane CD44. sHA also changes the motility properties of the Hs578T and MDA-231 cells and increases their CD44 expression. sHA or iHA have no measurable effect on the adhesion, motility or CD44 expression of the ZR-75-1 and MCF-7 breast cancer cells. Our results establish that in high CD44 expressing breast cancer cells HA modulates tumour cell adhesion and motility and also increases the expression of its own receptor, CD44.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11488992      PMCID: PMC2517708          DOI: 10.1046/j.1365-2613.2001.iep0082-0193-x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  27 in total

1.  Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: correlation with invasive potential.

Authors:  M Culty; M Shizari; E W Thompson; C B Underhill
Journal:  J Cell Physiol       Date:  1994-08       Impact factor: 6.384

2.  Hyaluronic acid induces tumour necrosis factor-alpha production by human macrophages in vitro.

Authors:  D E Boyce; A Thomas; J Hart; K Moore; K Harding
Journal:  Br J Plast Surg       Date:  1997-07

3.  Localization of hyaluronan in normal breast tissue, radial scar, and tubular breast carcinoma.

Authors:  M de la Torre; A F Wells; J Bergh; A Lindgren
Journal:  Hum Pathol       Date:  1993-12       Impact factor: 3.466

4.  Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines.

Authors:  E W Thompson; S Paik; N Brünner; C L Sommers; G Zugmaier; R Clarke; T B Shima; J Torri; S Donahue; M E Lippman
Journal:  J Cell Physiol       Date:  1992-03       Impact factor: 6.384

5.  Molecular and cellular analysis of basement membrane invasion by human breast cancer cells in Matrigel-based in vitro assays.

Authors:  S N Bae; G Arand; H Azzam; P Pavasant; J Torri; T L Frandsen; E W Thompson
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

6.  Migration of human melanoma cells on hyaluronate is related to CD44 expression.

Authors:  L Thomas; T Etoh; I Stamenkovic; M C Mihm; H R Byers
Journal:  J Invest Dermatol       Date:  1993-02       Impact factor: 8.551

7.  Hyaluronan as a propellant for epithelial movement: the development of semicircular canals in the inner ear of Xenopus.

Authors:  C M Haddon; J H Lewis
Journal:  Development       Date:  1991-06       Impact factor: 6.868

8.  Migration of highly aggressive melanoma cells on hyaluronic acid is associated with functional changes, increased turnover and shedding of CD44 receptors.

Authors:  M Goebeler; D Kaufmann; E B Bröcker; C E Klein
Journal:  J Cell Sci       Date:  1996-07       Impact factor: 5.285

9.  CD44H regulates tumor cell migration on hyaluronate-coated substrate.

Authors:  L Thomas; H R Byers; J Vink; I Stamenkovic
Journal:  J Cell Biol       Date:  1992-08       Impact factor: 10.539

10.  Hyaluronan fragments activate an NF-kappa B/I-kappa B alpha autoregulatory loop in murine macrophages.

Authors:  P W Noble; C M McKee; M Cowman; H S Shin
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

View more
  11 in total

1.  A structural analysis of glycosaminoglycans from lethal and nonlethal breast cancer tissues: toward a novel class of theragnostics for personalized medicine in oncology?

Authors:  Amanda Weyers; Bo Yang; Dae Sung Yoon; Jong-Hwan Park; Fuming Zhang; Kyung Bok Lee; Robert J Linhardt
Journal:  OMICS       Date:  2012-03

2.  Role of receptor for hyaluronic acid-mediated motility (RHAMM) in low molecular weight hyaluronan (LMWHA)-mediated fibrosarcoma cell adhesion.

Authors:  Katerina Kouvidi; Aikaterini Berdiaki; Dragana Nikitovic; Pavlos Katonis; Nikos Afratis; Vincent C Hascall; Nikos K Karamanos; George N Tzanakakis
Journal:  J Biol Chem       Date:  2011-09-13       Impact factor: 5.157

Review 3.  Hyaluronic acid in digestive cancers.

Authors:  Ruo-Lin Wu; Lei Huang; Hong-Chuan Zhao; Xiao-Ping Geng
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-17       Impact factor: 4.553

4.  In vivo evidence for the role of CD44s in promoting breast cancer metastasis to the liver.

Authors:  Allal Ouhtit; Zakaria Y Abd Elmageed; Mohamed E Abdraboh; Tong F Lioe; Madhwa H G Raj
Journal:  Am J Pathol       Date:  2007-11-08       Impact factor: 4.307

5.  Nucleolin: acharan sulfate-binding protein on the surface of cancer cells.

Authors:  Eun Ji Joo; Gerdy B ten Dam; Toin H van Kuppevelt; Toshihiko Toida; Robert J Linhardt; Yeong Shik Kim
Journal:  Glycobiology       Date:  2004-08-25       Impact factor: 4.313

6.  Intratumoral delivery of Paclitaxel in solid tumor from biodegradable hyaluronan nanoparticle formulations.

Authors:  Abeer M Al-Ghananeem; Ahmad H Malkawi; Yahya M Muammer; Justin M Balko; Esther P Black; Walid Mourad; Edward Romond
Journal:  AAPS PharmSciTech       Date:  2009-04-21       Impact factor: 3.246

Review 7.  Nanotechnology and Glycosaminoglycans: Paving the Way Forward for Ovarian Cancer Intervention.

Authors:  Yasar Hoosen; Priyamvada Pradeep; Pradeep Kumar; Lisa C du Toit; Yahya E Choonara; Viness Pillay
Journal:  Int J Mol Sci       Date:  2018-03-04       Impact factor: 5.923

8.  A Step Forward in Breast Cancer Research: From a Natural-Like Experimental Model to a Preliminary Photothermal Approach.

Authors:  Eduardo Costa; Tânia Ferreira-Gonçalves; Miguel Cardoso; João M P Coelho; Maria Manuela Gaspar; Pedro Faísca; Lia Ascensão; António S Cabrita; Catarina Pinto Reis; Isabel V Figueiredo
Journal:  Int J Mol Sci       Date:  2020-12-18       Impact factor: 5.923

9.  Virtual screening-driven repositioning of etoposide as CD44 antagonist in breast cancer cells.

Authors:  Charmina Aguirre-Alvarado; Aldo Segura-Cabrera; Inés Velázquez-Quesada; Miguel A Hernández-Esquivel; Carlos A García-Pérez; Sandra L Guerrero-Rodríguez; Angel J Ruiz-Moreno; Andrea Rodríguez-Moreno; Sonia M Pérez-Tapia; Marco A Velasco-Velázquez
Journal:  Oncotarget       Date:  2016-04-26

10.  Prognostic significance of receptor for hyaluronan acid-mediated motility (CD168) in acute pediatric leukemias - assessment of clinical outcome, post induction, end of treatment and minimal residual disease.

Authors:  Chinnathambi Narayanan Sai Shalini; Febe Renjitha Suman; Jerusha Samuela Jacob; Rithika Rajendran; Julius Xavier Scott; Magadha Sneha Latha
Journal:  Hematol Transfus Cell Ther       Date:  2018-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.